Navamedic ASA (OSL:NAVA)
Norway
· Delayed Price · Currency is NOK 20.10
-0.40 (-1.95%)
Mar 9, 2026, 4:27 PM CET
Navamedic ASA Income Statement
Financials in millions NOK. Fiscal year is January - December.
Millions NOK. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 565.36 | 531.44 | 512 | 382.14 | 278.44 | Upgrade
|
| Revenue Growth (YoY) | 6.38% | 3.80% | 33.98% | 37.24% | 32.67% | Upgrade
|
| Cost of Revenue | 345.04 | 325.92 | 313.63 | 218.62 | 166.7 | Upgrade
|
| Gross Profit | 220.32 | 205.52 | 198.37 | 163.52 | 111.74 | Upgrade
|
| Selling, General & Admin | 172.71 | 70.26 | 63.67 | 48.09 | 44.46 | Upgrade
|
| Amortization of Goodwill & Intangibles | 27.19 | 10.49 | 8.61 | 4.85 | 4.55 | Upgrade
|
| Other Operating Expenses | - | 88.7 | 83.13 | 63.75 | 49.12 | Upgrade
|
| Operating Expenses | 204.07 | 173.72 | 158.73 | 119.08 | 100.29 | Upgrade
|
| Operating Income | 16.25 | 31.8 | 39.64 | 44.45 | 11.46 | Upgrade
|
| Interest Expense | -28.06 | -10.01 | -7.77 | -0.61 | -2.5 | Upgrade
|
| Interest & Investment Income | - | 3.1 | 4.63 | 3.08 | 2.79 | Upgrade
|
| Earnings From Equity Investments | - | - | - | -1.1 | -3.19 | Upgrade
|
| Currency Exchange Gain (Loss) | - | -6.28 | 5.94 | -9.24 | -5.52 | Upgrade
|
| Other Non Operating Income (Expenses) | - | 6.91 | -6.43 | 13.58 | -0.68 | Upgrade
|
| EBT Excluding Unusual Items | -11.81 | 25.52 | 36.01 | 50.15 | 2.36 | Upgrade
|
| Merger & Restructuring Charges | -3.85 | - | -16.06 | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | - | -1.55 | -8.7 | -7.64 | - | Upgrade
|
| Other Unusual Items | - | -25.59 | -17.4 | - | - | Upgrade
|
| Pretax Income | -15.66 | -1.62 | -6.16 | 42.51 | 2.36 | Upgrade
|
| Income Tax Expense | 7.88 | 3.87 | 7.53 | 13.07 | 1.74 | Upgrade
|
| Earnings From Continuing Operations | -23.54 | -5.49 | -13.69 | 29.43 | 0.62 | Upgrade
|
| Net Income | -23.54 | -5.49 | -13.69 | 29.43 | 0.62 | Upgrade
|
| Net Income to Common | -23.54 | -5.49 | -13.69 | 29.43 | 0.62 | Upgrade
|
| Net Income Growth | - | - | - | 4662.46% | - | Upgrade
|
| Shares Outstanding (Basic) | - | 17 | 17 | 17 | 16 | Upgrade
|
| Shares Outstanding (Diluted) | - | 17 | 17 | 17 | 16 | Upgrade
|
| Shares Change (YoY) | - | 1.24% | 1.48% | 3.60% | 13.61% | Upgrade
|
| EPS (Basic) | - | -0.31 | -0.79 | 1.75 | 0.04 | Upgrade
|
| EPS (Diluted) | - | -0.31 | -0.79 | 1.73 | 0.04 | Upgrade
|
| EPS Growth | - | - | - | 4459.36% | - | Upgrade
|
| Free Cash Flow | 24.19 | 36.03 | -0.02 | 15.69 | -2.02 | Upgrade
|
| Free Cash Flow Per Share | - | 2.06 | -0.00 | 0.92 | -0.12 | Upgrade
|
| Gross Margin | 38.97% | 38.67% | 38.74% | 42.79% | 40.13% | Upgrade
|
| Operating Margin | 2.88% | 5.98% | 7.74% | 11.63% | 4.11% | Upgrade
|
| Profit Margin | -4.16% | -1.03% | -2.67% | 7.70% | 0.22% | Upgrade
|
| Free Cash Flow Margin | 4.28% | 6.78% | -0.00% | 4.11% | -0.73% | Upgrade
|
| EBITDA | 47.61 | 43.46 | 49.16 | 49.62 | 16.15 | Upgrade
|
| EBITDA Margin | 8.42% | 8.18% | 9.60% | 12.99% | 5.80% | Upgrade
|
| D&A For EBITDA | 31.36 | 11.66 | 9.52 | 5.18 | 4.69 | Upgrade
|
| EBIT | 16.25 | 31.8 | 39.64 | 44.45 | 11.46 | Upgrade
|
| EBIT Margin | 2.88% | 5.98% | 7.74% | 11.63% | 4.11% | Upgrade
|
| Effective Tax Rate | - | - | - | 30.76% | 73.79% | Upgrade
|
| Revenue as Reported | - | 531.44 | 512 | 382.14 | 278.44 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.